The pharmaceutical industry in the Philippines has been seeing stable growth for the past decade, and it looks set to continue. Though the market stood at $4.3bn in 2013, several recent and incoming changes could enable to sector to reach approximately $8bn by 2020. The increase is linked to the government’s intervention in price control and a...
Though health care sector spending is on the rise in the Philippines, years of underinvestment have resulted in a deficit in both available facilities and services. Although improvements are being made – in 2014 the Philippine government spending on health care reached the 5% of GDP recommended by the WHO – to reach the levels of care planned...
The Philippine experiment of combining public health care spending with private sector delivery continues to evolve. As health care remains central to the public interest, there is a heavy onus on improving access and efficiency in accordance with the goal of providing universal health care coverage for all Filipinos by 2016. The year 2015 is expected to focus on consolidation, as...
Revitalising a fragile education system, which was once considered amongst the best in South-east Asia, remains a top priority for Myanmar’s transitional government. However, rapid urbanisation, limited infrastructure, and a mesh of civil and religious unrest have left the Ministry of Education (MoE) with numerous hurdles to overcome. During the height of military rule,...
By most accounts, Myanmar has made significant economic progress in recent years, but general health care quality and access still lag dramatically behind that of its neighbours. Decades of mismanagement and limited funding has diminished the health sector and left it in dire need of reform, leaving the Ministry of Health (MoH) to fight an uphill battle. With life...
Valued at $480m in 2013 by the Ministry of Commerce, Myanmar’s pharmaceuticals industry offers drug makers a new opportunity, particularly over-the-counter manufacturers who stand to benefit from the country’s reopening. A dramatic increase in health expenditure coupled with rising per capita income is set to see the value of the industry grow to $945m in 2015, a nearly...
Stay updated on how some of the world’s most promising markets are being affected by the Covid-19 pandemic, and what actions governments and private businesses are taking to mitigate challenges and ensure their long-term growth story continues.
Register now and also receive a complimentary 2-month licence to the OBG Research Terminal.
Register Here×